Use of 2-phenylmorpholin-5-one derivatives
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 24, 2001
Grant Date -
N/A
app pub date -
Feb 25, 1999
filing date -
Aug 27, 1996
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A 2-phenylmorpholin-5-one derivative having the formula (I): ##STR1## wherein R.sub.1 represents a C.sub.1 to C.sub.8 alkyl group, a C.sub.3 to C.sub.7 cycloalkyl group or an indanyl group, R.sub.2 represents a C.sub.1 to C.sub.4 alkyl group, R.sub.3 represents a hydrogen atom, a C.sub.1 to C.sub.5 alkyl group, etc., R.sub.4 represents a hydrogen atom, a C.sub.1 to C.sub.6 alkyl group, etc., R.sub.5, R.sub.6 represent a hydrogen atom, a C.sub.1 to C.sub.5 alkyl group, etc., an optical isomer thereof or a pharmacologically acceptable salt thereof, or a hydrate or solvate thereof and a pharmaceutical composition containing the same. The above compound has a strong type IV phosphodiesterase (PDE) inhibitory activity and has bronchodilater and antiinflammatory effects.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully